Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Composition for preventing or treating keloid or hypertrophic scar

A technology for hypertrophic scars and keloids, which is applied in the field of keloids or compositions for the prevention or treatment of hypertrophic scars, and can solve the problems of no established methods and the like

Pending Publication Date: 2021-05-25
TEGO SCI
View PDF7 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Hypertrophic scars do not extend beyond the wound and fade over time, but keloids have the difference of growing wider than the damaged area over time, invading into normal skin
For the treatment of hypertrophic scars or keloids, attempts have been made including surgery, radiation therapy, steroid therapy, occlusive dressings made of silicone, and laser therapy, but only with limited efficacy and no established method

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Composition for preventing or treating keloid or hypertrophic scar
  • Composition for preventing or treating keloid or hypertrophic scar
  • Composition for preventing or treating keloid or hypertrophic scar

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0042] Human skin fibroblasts, normal tissue, and hypertrophic scar tissue preparations

[0043] Skin tissues used for the experiment were obtained from 3 patients, and IHC was performed using normal and scar tissues of men and women, and the effect of transformation by siRNA was observed using primary fibroblast cells derived from each tissue.

[0044] After washing the tissue with 70% ethanol, the tissue for IHC was isolated by trimming to remove fat and chopping. After further trimming of the remaining tissue, minced and put into a solution mixed with collagenase, trypsin and EDTA, cells were detached at 37°C and 100 rpm. The isolated cells were cultured in F12 medium supplemented with 10% fetal bovine serum (FBS) and gentamycin.

[0045] Comparison of expression of complement proteins by immunohistochemistry (IHC) experiments on hypertrophic scar tissue

[0046]Tissue obtained from biopsy (Biopsy) was put into O.C.T compound (Cell Poth, KMA-0100-00A) and frozen in dry ic...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to a pharmaceutical composition for preventing or treating a hypertrophic scar. The present inventors acknowledged that expression inhibition of thioredoxin 5, PRRC1, S100A11, galectin 1, filamin A, eukaryotic initiation factor-5A, annexin A2 and fatty acid binding proteins 5 can be a new target for relieving and treating a hypertrophic scar. According to the present invention, the treatability of a hypertrophic scar is confirmed by producing thioredoxin 5-, PRRC1-, S100A11-, galectin 1-, filamin A-, eukaryotic initiation factor-5A-, annexin A2- and FABP5-specific siRNAs. Therefore, the knockdown of the proteins or genes coding same induces cell death in a hypertrophic scar and reduces collagen expression and thus can be highly useful for scar treatment.

Description

technical field [0001] The present invention relates to a composition for preventing or treating keloid or hypertrophic scar. Background technique [0002] When the deep layer of the dermis is damaged due to surgery or trauma, the collagen in the dermis that maintains the tension of the skin is overproliferated, and the thinned skin is exposed after the wound heals, leaving traces of skin recovery. scar". This is the result of wound healing, or when the function of properly regulating and inhibiting the wound healing process is impaired, the abnormal dense growth of fibrous tissue can generate hypertrophic scars (Hypertrophic scars) or keloids (Keloid). Hypertrophic scars do not extend beyond the wound and fade over time, but keloids have the difference of growing wider than the damaged area over time, invading into normal skin. For the treatment of hypertrophic scars or keloids, attempts have been made including surgery, radiation therapy, steroid therapy, occlusive dress...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/7088A61K31/713A61P17/02G01N33/68C12Q1/6883
CPCC12N15/113C12Q1/6883C12Q2600/136C12Q2600/158C12N2310/14G01N33/6893G01N2800/20A61K31/713A61K31/7105A61K31/7088A61P17/02G01N33/6881G01N2500/04
Inventor 全世华郑淏允吴娜拉金伦希韩职铉文弦阿
Owner TEGO SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com